Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M336Revenue (TTM) $M638Net Margin (%)1.8Altman Z-Score1.6
Enterprise Value $M632EPS (TTM) $0.3Operating Margin %4.8Piotroski F-Score4
P/E(ttm)32.8Beneish M-Score-2.0Pre-tax Margin (%)2.7Higher ROA y-yN
Price/Book0.810-y EBITDA Growth Rate %15.2Quick Ratio1.5Cash flow > EarningsY
Price/Sales0.65-y EBITDA Growth Rate %9.3Current Ratio2.1Lower Leverage y-yN
Price/Free Cash Flow9.3y-y EBITDA Growth Rate %-29.9ROA % (ttm)1.3Higher Current Ratio y-yN
Dividend Yield %2.3PEG3.5ROE % (ttm)3.1Less Shares Outstanding y-yN
Payout Ratio %74.0Shares Outstanding M30.1ROIC % (ttm)3.5Gross Margin Increase y-yN

Gurus Latest Trades with ACET

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ACET is held by these investors:



ACET: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rogers StevenSVP, CHIEF LEGAL OFFICER 2017-09-08Sell2,000$10.348.03view
ROTH DOUGLAS ASr. Vice President & CFO 2017-09-07Sell96$10.486.58view
GUCCIONE SALVATORE J SRPRESIDENT AND CEO 2017-09-07Sell218$10.486.58view
Alaimo Charles JohnSENIOR VICE PRESIDENT 2017-09-06Sell5,282$10.545.98view
DEBENEDITTIS FRANKSr. Vice President 2017-09-06Sell3,016$10.476.69view
ROTH DOUGLAS ASr. Vice President & CFO 2017-09-06Sell6,500$10.476.69view
Rogers StevenSVP, CHIEF LEGAL OFFICER 2017-09-06Sell2,050$10.476.69view
EILENDER ALBERT LChairman 2017-09-06Sell9,530$10.476.69view
GUCCIONE SALVATORE J SRPRESIDENT AND CEO 2017-09-06Sell9,850$10.476.69view
Kaczmarek Walter J IIICOO 2017-09-05Sell2,635$10.575.68view

Press Releases about ACET :

Quarterly/Annual Reports about ACET:

News about ACET:

Articles On GuruFocus.com
ACETO Appoints William C. Kennally, III President and CEO Sep 27 2017 
ACETO to Present at the Morgan Stanley 15th Annual Global Healthcare Conference Sep 05 2017 
ACETO Board of Directors Declares Quarterly Cash Dividend Aug 24 2017 
ACETO Corporation Schedules Fourth Quarter & Fiscal 2017 Financial Results News Release and Conferen Aug 11 2017 
ACETO Subsidiary, Rising Pharmaceuticals, Announces Product Launches Jul 21 2017 
ACETO Subsidiary, Rising Pharmaceuticals, Launches Chlorthalidone Tablets, 25 mg and 50 mg, and Glip Jun 20 2017 
ACETO Subsidiary, Rising Pharmaceuticals, Launches Atomoxetine Capsules, 10, 18, 25, 40, 60, 80 & 10 May 31 2017 
ACETO Board of Directors Declares Quarterly Cash Dividend  May 04 2017 
ACETO Corporation Schedules Third Quarter Fiscal 2017 Financial Results News Release and Conference Apr 21 2017 
ACETO Subsidiary, Rising Pharmaceuticals, Launches Zileuton Extended Release Tablets, 600 mg Mar 31 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK